The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Most Britons could soon use weight loss jabs to live longer, Britain’s most eminent medic has said. Experts hailed a “golden age” in obesity treatment thanks to drugs which have been found to halve ...

The NHS has been urged to accelerate the rollout of weight loss drugs to “many millions” of people, as experts hailed the start of a “golden age” of anti-obesity treatments. A raft of studies ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

Researchers at the University of Michigan have developed DT-109, a compound that reduces fatty liver disease and ...

Hidden fat stored deep within muscles can significantly raise your risk of heart disease, heart attacks, and heart failure, ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Cytokinetics said on Tuesday its experimental heart disease drug significantly improved patients' ability to exercise compared to standard-of-care treatment in a late-stage study, sending shares of ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

From genetic risks to inflammation markers, uncover the latest insights in cardiovascular prevention that every primary care ...

The best metric is not weight, but a particularly toxic kind of fat.

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and ...